MANE vs MCK
Veradermics, Incorporated vs McKesson Corporation — AI-powered side-by-side comparison
MANE
Veradermics, Incorporated
69
Buy
VS
MCK
McKesson Corporation
57
Buy
| Metric | MANE | MCK |
|---|
| AI Score |
69
|
57
|
| Price |
$102.81
|
$860.44
|
| P/E Ratio |
-48.05×
|
22.89×
|
| ROE |
57.8%
|
-219.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
0.0%
|
3.6%
|
| Debt / Equity |
0.00×
|
-2.76×
|
| Dividend Yield |
0.0%
|
0.4%
|
| RSI (14) |
35.5
|
50.5
|
| Beta |
1.3492
|
0.307
|
| Expected Upside |
+13.1%
|
+4.1%
|
AI Committee View
Current Innellis committee reasoning for MANE versus MCK.
MANE leads by 12 points.
MANE scores 69/100 (Buy) versus MCK at 57/100 (Buy).
MANE Committee View
100% agreement
5 analysts
The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. The main limiting factor is sector concentration is already high (hhi 3069.37). The committee is constructive but not yet at full conviction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
Bear Case
- MACD histogram negative -- bearish momentum — Technical
MCK Committee View
67% agreement
6 analysts
The primary driver is news sentiment is positive (+0.27 across 20 articles, 14d). The main limiting factor is current ratio of 0.85 is tight -- limited short-term liquidity cushion. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 39.4% shows genuine earnings power backing the valuation — Value
- EPS growing 49.1% YoY — Growth
- 5 consecutive earnings beats -- consistent execution — Growth
Bear Case
- Price-to-book of 4.3x prices in significant intangible value — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical